Division of Infectious Diseases and Immunology Research | NYU Langone Health

Skip to Main Content

Division of Infectious Diseases and Immunology Research

We focus on research to find new ways to prevent, diagnose, and treat infectious diseases.

At NYU Langone’s Division of Infectious Diseases and Immunology, we believe that research is the engine that drives new medical advances to protect and restore public health locally and globally. Research is an important part of our mission, and our goal is to translate scientific research into innovative ways to prevent, diagnose, and treat infectious diseases.

Our research activities cover the entire span of biomedical discovery—from preclinical laboratory research using animal models, to clinical studies and clinical trials that translate into clinical practice. We also conduct research on healthcare policy, education, and behavior.

We are dedicated to training the next generation of research leaders in the field of infectious diseases and immunology. Important research initiatives within our division include the Vaccine Center, NYU Langone Molecular Outbreak Program, Special Pathogens Program at NYC Health + Hospitals/Bellevue, and hepatitis C elimination studies, as well as research on Staphylococcus aureus bacteria, hepatitis B, influenza, universal flu vaccine, flaviviruses, and yellow fever virus vaccines.

Core Faculty Investigators

Benjamin J. Eckhardt, MD
Assistant Professor, Department of Medicine
Lead Investigator, Hepatitis C Elimination Studies

Ramin Herati, MD
Assistant Professor, Department of Medicine

Mark J. Mulligan, MD
Director, Division of Infectious Diseases and Immunology
Director, Vaccine Center
The Thomas S. Murphy Sr. Professor, Department of Medicine

Bo Shopsin, MD, PhD
Associate Director, Research, Division of Infectious Diseases
Director, Molecular Epidemiology Director, Antimicrobial-Resistant Pathogens
Program Associate Director of MSTP Curriculum and Programming
Associate Professor, Department of Microbiology

Scott A. Weisenberg, MD
Medical Director, NYU Langone Infectious Disease Associates
Medical Director, Travel Medicine Program
Clinical Associate Professor, Department of Medicine

Faculty Publications

Our faculty publish their research in leading peer-reviewed journals. Learn more about their recent publications.

SARS-CoV-2 inflammation durably imprints memory CD4 T cells

Gray-Gaillard, Sophie L; Solis, Sabrina M; Chen, Han M; Monteiro, Clarice; Ciabattoni, Grace; Samanovic, Marie I; Cornelius, Amber R; Williams, Tijaana; Geesey, Emilie; Rodriguez, Miguel; Ortigoza, Mila Brum; Ivanova, Ellie N; Koralov, Sergei B; Mulligan, Mark J; Herati, Ramin Sedaghat

Science immunology. 2024 Jun 21; 9:eadj8526

The immunodominance of antigenic site Sb on the H1 influenza virus hemagglutinin increases with high immunoglobulin titers of the cohorts and with young age, but not sex

Martínez, Jose L; Lemus, Nicholas; Lai, Tsoi Ying; Mishra, Mitali; González-Domínguez, Irene; Puente-Massaguer, Eduard; Loganathan, Madhumathi; Francis, Benjamin; Samanovic, Marie I; Krammer, Florian; Mulligan, Mark J; Simon, Viviana; Palese, Peter; Sun, Weina

Vaccine. 2024 May 22; 42:3365-3373

The urgent need to implement point-of-care RNA testing for hepatitis C virus to support elimination

Kapadia, Shashi N; Jordan, Ashly E; Eckhardt, Benjamin J; Perlman, David C

Clinical infectious diseases. 2024 May 15; 78:1235-1239

Phase 1 Open-Label Dose Escalation Trial for the Development of a Human Bacillus Calmette-Guérin Challenge Model for Assessment of Tuberculosis Immunity In Vivo

Blazevic, Azra; Edwards, Rachel L; Xia, Mei; Eickhoff, Christopher S; Hamzabegovic, Fahreta; Meza, Krystal A; Ning, Huan; Tennant, Janice; Mosby, Karla J; Ritchie, James C; Girmay, Tigisty; Lai, Lilin; McCullough, Michele; Beck, Allison; Kelley, Colleen; Edupuganti, Srilatha; Kabbani, Sarah; Buchanan, Wendy; Makhene, Mamodikoe K; Voronca, Delia; Cherikh, Sami; Goll, Johannes B; Rouphael, Nadine G; Mulligan, Mark J; Hoft, Daniel F

Journal of infectious diseases. 2024 May 15; 229:1498-1508

Longitudinal study of immunity to SARS-CoV2 in ocrelizumab-treated MS patients up to 2 years after COVID-19 vaccination

Kister, Ilya; Curtin, Ryan; Piquet, Amanda L; Borko, Tyler; Pei, Jinglan; Banbury, Barbara L; Bacon, Tamar E; Kim, Angie; Tuen, Michael; Velmurugu, Yogambigai; Nyovanie, Samantha; Selva, Sean; Samanovic, Marie I; Mulligan, Mark J; Patskovsky, Yury; Priest, Jessica; Cabatingan, Mark; Winger, Ryan C; Krogsgaard, Michelle; Silverman, Gregg J

Annals of clinical and translational neurology. 2024 May 07;

Crimean Congo Hemorrhagic Fever Virus for Clinicians-Virology, Pathogenesis, and Pathology

Frank, Maria G; Weaver, Gretchen; Raabe, Vanessa; ,

Emerging infectious diseases. 2024 May ; 30:847-853

Crimean-Congo Hemorrhagic Fever Virus for Clinicians-Diagnosis, Clinical Management, and Therapeutics

Frank, Maria G; Weaver, Gretchen; Raabe, Vanessa; ,; ,; ,

Emerging infectious diseases. 2024 May ; 30:864-873

Crimean-Congo Hemorrhagic Fever Virus for Clinicians-Epidemiology, Clinical Manifestations, and Prevention

Frank, Maria G; Weaver, Gretchen; Raabe, Vanessa; ,; ,; ,

Emerging infectious diseases. 2024 May ; 30:854-863